Therapy Shows High Remission Rates in Multiple Myeloma – Curetoday.com
|
Therapy Shows High Remission Rates in Multiple Myeloma
Curetoday.com This is one of the first clinical trials of CAR T cells targeting BCMA, which was discovered to play a role in progression of multiple myeloma in 2004. Data from previous trials has shown CAR T-cell therapy targeting the protein CD19 to have efficacy … |
